Compare HNNA & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HNNA | LNSR |
|---|---|---|
| Founded | 1989 | 2004 |
| Country | United States | United States |
| Employees | 18 | N/A |
| Industry | Investment Managers | Medical Electronics |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.9M | 69.1M |
| IPO Year | N/A | 2005 |
| Metric | HNNA | LNSR |
|---|---|---|
| Price | $9.87 | $5.21 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 4.1K | ★ 32.0K |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | ★ 5.57% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $58,435,000.00 |
| Revenue This Year | N/A | $10.06 |
| Revenue Next Year | N/A | $41.48 |
| P/E Ratio | $8.77 | ★ N/A |
| Revenue Growth | N/A | ★ 9.24 |
| 52 Week Low | $8.90 | $5.06 |
| 52 Week High | $13.00 | $13.20 |
| Indicator | HNNA | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 42.48 | 33.89 |
| Support Level | $9.65 | $5.06 |
| Resistance Level | $10.32 | $6.47 |
| Average True Range (ATR) | 0.14 | 0.18 |
| MACD | -0.03 | -0.06 |
| Stochastic Oscillator | 10.42 | 5.17 |
Hennessy Advisors Inc is an investment management company that manages and markets open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, multi-asset sectors, specialty products, and fixed income products. The company earns revenues mainly from investment advisory services and secondarily from shareholder services. Advisory services include managing each fund's portfolio in line with its investment objectives, monitoring compliance and performance, overseeing sub-advisors and other service providers, and handling marketing, distribution, and regulatory reporting. Shareholder services cover investor support and coordination with the fund service provider, with all related fees based on the funds' average daily net asset values.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.